Organon tightens 2022 revenue guidance on forex headwinds (NYSE:OGN)
Zerbor/iStock through Getty Images Despite reporting higher than anticipated financials for 2Q 2022, Organon (NYSE:OGN), Merck’s (MRK) spinoff centered on ...
Zerbor/iStock through Getty Images Despite reporting higher than anticipated financials for 2Q 2022, Organon (NYSE:OGN), Merck’s (MRK) spinoff centered on ...